{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:29:14Z","timestamp":1792211354546,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016330","name":"Henan Provincial People's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cellsig.2026.112447","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:57:25Z","timestamp":1771952245000},"page":"112447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Circ_0057105 promotes intrahepatic cholangiocarcinoma progression by sponging miR-1290 and regulating the MDM2\/P53 pathway"],"prefix":"10.1016","volume":"143","author":[{"given":"Taiyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cellsig.2026.112447_bb0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112447_bb0010","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112447_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.5679","article-title":"Association of KRAS variant subtypes with survival and recurrence in patients with surgically treated intrahepatic cholangiocarcinoma","volume":"157","author":"Zhou","year":"2022","journal-title":"JAMA Surg."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112447_bb0025","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41575-019-0217-8","article-title":"Metabolic rearrangements in primary liver cancers: cause and consequences","volume":"16","author":"Satriano","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112447_bb0030","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","article-title":"Small and long non-coding RNAs: past, present, and future","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1086-z","article-title":"The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma","volume":"18","author":"Wei","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-022-02494-z","article-title":"CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3\u03b6","volume":"41","author":"Hao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01607-8","article-title":"Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway","volume":"21","author":"Xu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1054-7","article-title":"Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p\/SIX1\/vimentin axis","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112447_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217120","article-title":"Therapeutic SHPRH-146aa encoded by circ-SHPRH dynamically upregulates P21 to inhibit CDKs in neuroblastoma","volume":"598","author":"Chang","year":"2024","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112447_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03276-1","article-title":"CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p\/RTKN2 axis and activating Wnt\/\u03b2-catenin pathway","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0827-8","article-title":"Circular RNAs function as ceRNAs to regulate and control human cancer progression","volume":"17","author":"Zhong","year":"2018","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112447_bb0070","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7150\/thno.104698","article-title":"Optimized circular RNA vaccines for superior cancer immunotherapy","volume":"15","author":"Yu","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02620-5","article-title":"Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-𝜅B-IL-6 axis of tumor-associated macrophages","volume":"42","author":"Zhou","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112447_bb0080","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","article-title":"Understanding the complexity of p53 in a new era of tumor suppression","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"issue":"5652","key":"10.1016\/j.cellsig.2026.112447_bb0085","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.1091362","article-title":"Mono- versus polyubiquitination: differential control of p53 fate by Mdm2","volume":"302","author":"Li","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112447_bb0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep.22675","article-title":"Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner","volume":"49","author":"Zhu","year":"2009","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.cellsig.2026.112447_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105077","article-title":"Chitosan-gelatin-EGCG nanoparticle-meditated LncRNA TMEM44-AS1 silencing to activate the P53 signaling pathway for the synergistic reversal of 5-FU resistance in gastric cancer","volume":"9","author":"Zhou","year":"2022","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112447_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1339","article-title":"Hsa_circ_0057105 modulates a balance of epithelial-mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma","volume":"13","author":"Cen","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112447_bb0105","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.1021\/jacs.4c16613","article-title":"Pistol ribozyme-driven catalytic spherical nucleic acid integrates gene and Chemotherapy for enhanced Cancer therapy","volume":"147","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01883-y","article-title":"Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375\/PRKDC Axis and PD-L1 phosphorylation","volume":"22","author":"Miao","year":"2023","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112447_bb0115","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"issue":"51","key":"10.1016\/j.cellsig.2026.112447_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for Cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112447_bb0125","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","article-title":"Lipids and Lipid Derivatives for RNA Delivery","volume":"121","author":"Zhang","year":"2021","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112447_bb0130","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","article-title":"A thermostable mRNA vaccine against COVID-19","volume":"182","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112447_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/OTT.S437536","article-title":"Crosstalk between circRNA and tumor microenvironment of hepatocellular carcinoma: mechanism, function and applications","volume":"17","author":"Xie","year":"2024","journal-title":"Onco. Targets Ther."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112447_bb0140","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41418-018-0220-6","article-title":"Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes","volume":"26","author":"Chen","year":"2018","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112447_bb0145","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13432","article-title":"Proangiogenic role of circRNA-007371 in liver fibrosis","volume":"56","author":"Zhao","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.cellsig.2026.112447_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","article-title":"CircRNA in cancer: fundamental mechanism and clinical potential","volume":"505","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02295-w","article-title":"CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112447_bb0160","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jnci\/djp355","article-title":"Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53","volume":"101","author":"Van Maerken","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molmed.2006.11.002","article-title":"MDM2 inhibitors for cancer therapy","volume":"13","author":"Vassilev","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"5659","key":"10.1016\/j.cellsig.2026.112447_bb0170","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112447_bb0175","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11523-024-01086-5","article-title":"The epidemiology of biliary tract Cancer and associated prevalence of MDM2 amplification: a targeted literature review","volume":"19","author":"Kratz","year":"2024","journal-title":"Target. Oncol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112447_bb0180","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1053\/j.gastro.2015.08.045","article-title":"Burden of gastrointestinal, liver, and pancreatic diseases in the United States","volume":"149","author":"Peery","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112447_bb0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","article-title":"HCC and angiogenesis: possible targets and future directions","volume":"8","author":"Zhu","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"29","key":"10.1016\/j.cellsig.2026.112447_bb0190","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1093\/eurheartj\/ehad377","article-title":"A2AR-mediated lymphangiogenesis via VEGFR2 signaling prevents salt-sensitive hypertension","volume":"44","author":"Zhuang","year":"2023","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112447_bb0195","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1038\/sj.emboj.7601297","article-title":"p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy","volume":"25","author":"Zwang","year":"2006","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1010-6","article-title":"A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via hippo-YAP signaling","volume":"18","author":"Zheng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112447_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216219","article-title":"CircRNAs in tumor immunity and immunotherapy: perspectives from innate and adaptive immunity","volume":"564","author":"Yu","year":"2023","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112447_bb0210","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ccell.2018.05.006","article-title":"BAI1 suppresses Medulloblastoma formation by protecting p53 from Mdm2-mediated degradation","volume":"33","author":"Zhu","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112447_bb0215","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.molcel.2014.04.024","article-title":"Gain-of-function mutant p53 promotes cell growth and Cancer cell metabolism via inhibition of AMPK activation","volume":"54","author":"Zhou","year":"2014","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112447_bb0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2012.10.038","article-title":"Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells","volume":"329","author":"Wu","year":"2013","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0225","article-title":"The role and potential mechanisms of exosomes in the progression of hepatocellular carcinoma","volume":"4","author":"Tong","year":"2025","journal-title":"Holist. Integr. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112447_bb0230","article-title":"Novel therapeutic approaches to cancer immunotherapy and mRNA vaccines technology: a review","volume":"4","author":"Adebanjo","year":"2025","journal-title":"Holist. Integr. Oncol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:26:59Z","timestamp":1777580819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["S0898656826000975"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112447","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circ_0057105 promotes intrahepatic cholangiocarcinoma progression by sponging miR-1290 and regulating the MDM2\/P53 pathway","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112447"}}